Based on the C4 Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for C4 Therapeutics Inc is USD 14.00 over the next 12 months. C4 Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of C4 Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, C4 Therapeutics Inc’s stock price was USD 6.04. C4 Therapeutics Inc’s stock price has changed by -13.71% over the past week, -2.11% over the past month and +292.21% over the last year.
No recent analyst target price found for C4 Therapeutics Inc
No recent average analyst rating found for C4 Therapeutics Inc
Company Overview C4 Therapeutics Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for C4 Therapeutics Inc (CCCC)
Loading...
Unadjusted Closing Price for C4 Therapeutics Inc (CCCC)
Loading...
Share Trading Volume for C4 Therapeutics Inc Shares
Loading...
Compare Performance of C4 Therapeutics Inc Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for CCCC
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To C4 Therapeutics Inc (Sector: Biotechnology )
Frequently Asked Questions About C4 Therapeutics Inc (CCCC) Stock
Based on ratings from 3 analysts C4 Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 2 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on CCCC's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for CCCC is USD 14.00 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 8.
Unfortunately we do not have enough data on CCCC's stock to indicate if its overvalued.
The last closing price of CCCC's stock was USD 6.04.
Unfortunately we do not currently have any market capitalization data for CCCC's stock.
Based on targets from 3 analysts, the average taret price for CCCC is projected at USD 14.00 over the next 12 months.
This means that CCCC's stock price may go up by +131.79% over the next 12 months.
We can't find any ETFs which contains C4 Therapeutics Inc's stock.
Sorry, we do not have any data on the number of employees for C4 Therapeutics Inc.
Sorry we do not have any infomation available on C4 Therapeutics Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About C4 Therapeutics Inc (CCCC) Stock
Based on ratings from 3 analysts C4 Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 2 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on CCCC's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for CCCC is USD 14.00 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 8.
Unfortunately we do not have enough data on CCCC's stock to indicate if its overvalued.
The last closing price of CCCC's stock was USD 6.04.
Unfortunately we do not currently have any market capitalization data for CCCC's stock.
Based on targets from 3 analysts, the average taret price for CCCC is projected at USD 14.00 over the next 12 months.
This means that CCCC's stock price may go up by +131.79% over the next 12 months.
We can't find any ETFs which contains C4 Therapeutics Inc's stock.
Sorry, we do not have any data on the number of employees for C4 Therapeutics Inc.
Sorry we do not have any infomation available on C4 Therapeutics Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CCCC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
